Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 382186, 10 pages
http://dx.doi.org/10.1155/2015/382186
Clinical Study

The Relationship between Clinical Feature, Complex Immunophenotype, Chromosome Karyotype, and Outcome of Patients with Acute Myeloid Leukemia in China

1Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2Hematology Department, Kanghua Hospital, Dongguan 523080, China

Received 23 January 2015; Accepted 20 March 2015

Academic Editor: Marco E. M. Peluso

Copyright © 2015 Bingjie Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Urbano-Ispizua, E. Matutes, N. Villamor et al., “Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia,” British Journal of Haematology, vol. 75, no. 2, pp. 202–207, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Matutes, R. Morilla, N. Farahat et al., “Definition of acute biphenotypic leukemia,” Haematologica, vol. 82, no. 1, pp. 64–66, 1997. View at Google Scholar · View at Scopus
  3. M. C. Bene, G. Castoldi, W. Knapp et al., “Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL),” Leukemia, vol. 9, no. 10, pp. 1783–1786, 1995. View at Google Scholar · View at Scopus
  4. L. Yan, N. Ping, M. Zhu et al., “Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification,” Haematologica, vol. 97, no. 11, pp. 1708–1712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Deffis-Court, M. Alvarado-Ibarra, G. J. Ruiz-Argüelles et al., “Diagnosing and treating mixed phenotype acute leukemia: a multicenter 10-year experience in México,” Annals of Hematology, vol. 93, no. 4, pp. 595–601, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. X.-Q. Xu, J.-M. Wang, S.-Q. Lü et al., “Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population,” Haematologica, vol. 94, no. 7, pp. 919–927, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Killick, E. Matutes, R. L. Powles et al., “Outcome of biphenotypic acute leukemia,” Haematologica, vol. 84, no. 8, pp. 699–706, 1999. View at Google Scholar · View at Scopus
  8. J. W. Vardiman, “The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms,” Chemico-Biological Interactions, vol. 184, no. 1-2, pp. 16–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kantarjian, S. O'Brisn, J. Cortes et al., “Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome,” Cancer, vol. 106, no. 5, pp. 1090–1098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Grimwade, R. K. Hills, A. V. Moorman et al., “Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials,” Blood, vol. 116, no. 3, pp. 354–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. W. van den Ancker, M. Terwijn, T. M. Westers et al., “Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification,” Leukemia, vol. 24, no. 7, pp. 1392–1396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Matutes, W. F. Pickl, M. van't Veer et al., “Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification,” Blood, vol. 117, no. 11, pp. 3163–3171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Atfy, N. M. A. Al Azizi, and A. M. Elnaggar, “Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: and its role in their outcome,” Leukemia Research, vol. 35, no. 10, pp. 1339–1344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Bachir, J. Zerrouk, S. C. Howard et al., “Outcomes in patients with mixed phenotype acute leukemia in Morocco,” Journal of Pediatric Hematology/Oncology, vol. 36, no. 6, pp. e392–e397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. E. G. Weir, M. A. Ansari-Lari, D. A. S. Batista et al., “Acute bilineal leukemia: a rare disease with poor outcome,” Leukemia, vol. 21, no. 11, pp. 2264–2270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Mejstrikova, J. Volejnikova, E. Fronkova et al., “Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria,” Haematologica, vol. 95, no. 6, pp. 928–935, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Legrand, J.-Y. Perrot, G. Simonin et al., “Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression,” British Journal of Haematology, vol. 100, no. 1, pp. 147–155, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Schoch, T. Haferlach, D. Haase et al., “Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients,” British Journal of Haematology, vol. 112, no. 1, pp. 118–126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Bowen, M. J. Groves, A. K. Burnett et al., “TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis,” Leukemia, vol. 23, no. 1, pp. 203–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Mikulic, D. Batinic, M. Sucic et al., “Biological features and outcome of biphenotypic acute leukemia: a case series,” Hematology/Oncology and Stem Cell Therapy, vol. 1, no. 4, pp. 225–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. O. Casasnovas, F. K. Slimane, R. Garand et al., “Immunological classification of acute myeloblastic leukemias: relevance to patient outcome,” Leukemia, vol. 17, no. 3, pp. 515–527, 2003. View at Publisher · View at Google Scholar · View at Scopus